Latent Labs

latentlabs.bsky.social

23 March 2026 08:13

Drug discovery has long been bottlenecked not by hits, but by development. Latent-X2 is our step toward designing the right molecule from the start. Technical report: tinyurl.com/latent-X2-re... Blog: www.latentlabs.com/latent-x2 Apply for access: partnerships@latentlabs.com

Latent Labs

latentlabs.bsky.social

23 March 2026 08:12

To enable reproduction, we're publishing the sequences and structures of a lab-validated antibody design for each target — accessible on the Latent Labs Platform without sign-in.

Latent Labs

latentlabs.bsky.social

23 March 2026 08:12

5 months from Latent-X1 to Latent-X2. AI-generated antibodies with drug-like developability and low immunogenicity in human panels — zero-shot. Available now for selected partners.

Gabriele Corso

gcorso.bsky.social

16 January 2026 17:22

Big news from Boltz today: we’re launching Boltz Lab, a new platform with new small-molecule + protein design agents, announcing Boltz PBC and a $28M seed round, and sharing a multi-year partnership with Pfizer. More below!

Umberto Lupo

umbislupo.bsky.social

16 January 2026 17:18

I've had the pleasure of working on this in collaboration with my very sharp colleagues at Absci. We look forward to feedback on all aspects of our design pipeline and preprint! [9/n, n=9]